In this article, Sian Gill, managing partner at leading full-service IP firm Venner Shipley, explores the acceleration of the global pharmaceuticals sector and explains why protecting IP is essential to maximising its long-term growth.
Neil Smith, CPG president, Schneider Electric comments on the importance of the upcoming UK Point of Care manufacturing legislation that came into force today (23rd July 2025).
As the UK’s transition away from F-gases ramps up, Aggreko has published a new report to provide clarity on the latest regulations and offer businesses guidance on the phase-down.
The UK government has announced a new Life Sciences Sector Plan aimed at strengthening the economy and modernising the NHS, marking a significant step in its wider Industrial Strategy.
For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications. Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.
British pharmaceutical companies are set to gain up to £250 million over the next five years as part of a Vietnamese law change that makes it easier to sell UK-made medicines to the country.
Speaking at the Medicines for Europe Annual Conference, Michal Nitka, SVP head generics Europe & global head OTC at Teva Pharmaceuticals, highlights the essential role of a resilient, competitive, and environmentally sustainable pharma industry.
Despite its growing threat to global health, research aimed at tackling antimicrobial resistance (AMR) has been constrained for many years, most likely due to the rapid evolution of resistance in pathogens, regulatory and policy barriers.
Dr. Werner Engelbrecht, senior director strategy, Veeva Systems explores how this year could see clinical trial innovation surge as EU regulation evolves.
Europe’s rollout of ISO IDMP product data standards is well underway now, and EMA’s aligned Product Management Services (PMS) platform, now live, is the next priority - with deadlines for enriching existing data hitting from the end of this year.
